Revolution Medicines Inc (RVMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 351,595 | 104,268 | 64,871 | 23,976 | 182,669 |
| Marketable Securities | 329,998 | 336,473 | 401,269 | 301,469 | 165,279 |
| Receivables | 7,564 | 6,393 | 9,299 | 7,331 | 8,450 |
| TOTAL | $697,405 | $454,122 | $482,898 | $340,381 | $362,086 |
| Non-Current Assets | |||||
| PPE Net | 10,879 | 8,902 | 7,035 | 7,102 | 6,775 |
| Intangibles | 75,286 | 75,553 | 75,820 | 76,087 | 76,354 |
| Other Non-Current Assets | 28,081 | 28,824 | 29,317 | 30,387 | 9,126 |
| TOTAL | $114,246 | $113,279 | $112,172 | $113,576 | $92,255 |
| Total Assets | $811,651 | $567,401 | $595,070 | $453,957 | $454,341 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,650 | 12,609 | 6,656 | 10,173 | 7,877 |
| Accrued Expenses | 20,445 | 18,784 | 18,974 | 15,363 | 13,950 |
| TOTAL | $43,759 | $47,176 | $42,384 | $43,737 | $41,514 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 9,964 | 12,111 | 13,109 | 14,582 | 16,402 |
| Other Non-Current Liabilities | 29,733 | 29,624 | 30,758 | 31,028 | 7,992 |
| TOTAL | $45,312 | $45,549 | $47,616 | $49,722 | $27,511 |
| Total Liabilities | $89,071 | $92,725 | $90,000 | $93,459 | $69,025 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 73,443 | 73,383 | 66,380 | 65,926 | 59,014 |
| Common Shares | 8 | 7 | 7 | 6 | 6 |
| Retained earnings | -302,721 | -265,545 | -231,341 | -204,120 | -176,905 |
| Other shareholders' equity | 63 | 116 | 211 | 291 | 36 |
| TOTAL | $722,580 | $474,676 | $505,070 | $360,498 | $385,316 |
| Total Liabilities And Equity | $811,651 | $567,401 | $595,070 | $453,957 | $454,341 |